Fluconazole vs Ketoconazole for Esophageal Candidiasis in Immunocompromised Patients

This study focuses on comparing two medications, fluconazole and ketoconazole, in the treatment of a condition called candidal esophagitis, which is an infection in the esophagus caused by a type of fungus called candida. The study involves immunocompromised patients, or individuals with weakened immune systems, who are more susceptible to such infections. The main goal is to find out which of these two medications works better and is safer for these patients, potentially improving their care and addressing the challenges posed by this condition. During the study, participants receive either fluconazole or ketoconazole as their treatment. The study then measures and compares the safety, tolerance, and effectiveness of these two medications. This involves evaluating how well each medication fights the infection, how well each is tolerated by the patients, and any potential side effects that may occur. The findings of this study could help determine the best treatment approach for candidal esophagitis in immunocompromised patients.